Reporter nanoparticle that monitors its anticancer efficacy in real time
The ability to monitor the efficacy of an anticancer treatment in real time can have a critical effect on the outcome. Currently, clinical readouts of efficacy rely on indirect or anatomic measurements, which occur over prolonged time scales postchemotherapy or postimmunotherapy and may not be conco...
Main Authors: | Sabbisetti, Venkata S., Mashelkar, Raghunath A., Kulkarni, Ashish, Natarajan, Siva, Rao, Poornima, Goldman, Aaron, Khater, Yashika, Korimerla, Navya, Chandrasekar, Vineethkrishna, Sengupta, Shiladitya |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2017
|
Online Access: | http://hdl.handle.net/1721.1/106793 |
Similar Items
-
Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy
by: Mashelkar, Raghunath Anant, et al.
Published: (2010) -
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
by: Goldman, Aaron, et al.
Published: (2015) -
Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity
by: Sengupta, Poulomi, et al.
Published: (2013) -
Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects
by: Molavian, Hamid R., et al.
Published: (2016) -
Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype
by: Connor, Yamicia, et al.
Published: (2016)